Changing the paradigm: valsartan-inhibitor of neprilysin, a new dual-acting drug for arterial hypertension and heart failure

Saved in:
Bibliographic Details
Published inHipertension y riesgo vascular Vol. 32; no. 1; p. 1
Main Authors Galve, E, Casas-Masnou, G, García-Dorado, D
Format Journal Article
LanguageSpanish
Published Spain 01.01.2015
Subjects
Angiotensin-Converting Enzyme Inhibitors - therapeutic use
Antihypertensive Agents - therapeutic use
Drug Therapy, Combination
Heart Failure - drug therapy
Humans
Hypertension - drug therapy
Neprilysin - therapeutic use
Tetrazoles - therapeutic use
Valine - therapeutic use
Valsartan
Online AccessGet more information

Cover

More Information
ISSN:1989-4805
DOI:10.1016/j.hipert.2014.11.001